期刊论文详细信息
Nutrition Journal
Zingiberaceae extracts for pain: a systematic review and meta-analysis
Deborah Tepper3  Christopher T. Ford1  Shaheen E. Lakhan2 
[1] Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, The University of Liverpool, Liverpool, UK;Global Neuroscience Initiative Foundation, Los Angeles, California, USA;Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA
关键词: Curcuma;    Curcumin;    Galangal;    Turmeric;    Ginger;    VAS;   
Others  :  1222663
DOI  :  10.1186/s12937-015-0038-8
 received in 2015-03-21, accepted in 2015-05-06,  发布年份 2015
PDF
【 摘 要 】

Background

Members of the family Zingiberaceae including turmeric, ginger, Javanese ginger, and galangal have been used for centuries in traditional medicine. Preclinical studies of Zingiberaceae extracts have shown analgesic properties. This study aims to systematically review and meta-analyze whether extracts from Zingiberaceae are clinically effective hypoalgesic agents.

Methods

Literature was screened from electronic databases using the key words Zingiberaceae AND pain OR visual analogue score (VAS) to identify randomized trials. From this search, 18 studies were identified, and of these, 8 randomized, double-blinded, placebo-controlled trials were found that measured pain by VAS for inclusion in the meta-analysis.

Results

Findings indicated significant efficacy of Zingiberaceae extracts in reducing subjective chronic pain (SMD − 0.67; 95 % CI − 1.13 to − 0.21; P = 0.004). A linear dose-effect relationship was apparent between studies (R2 = 0.71). All studies included in the systematic review reported a good safety profile for extracts, without the renal risks associated with non-steroidal anti-inflammatory drugs, and with similar effectiveness.

Conclusion

Our findings indicated that Zingiberaceae extracts are clinically effective hypoalgesic agents and the available data show a better safety profile than non-steroidal anti-inflammatory drugs. However, both non-steroidal anti-inflammatory drugs and Zingiberaceae have been associated with a heightened bleeding risk, and there have been no comparator trials of this risk. Further clinical studies are recommended to identify the most effective type of Zingiberaceae extract and rigorously compare safety, including bleeding risk.

【 授权许可】

   
2015 Lakhan et al.; licensee BioMed Central.

【 预 览 】
附件列表
Files Size Format View
20150824115402229.pdf 757KB PDF download
Fig. 4. 8KB Image download
Fig. 3. 20KB Image download
Fig. 2. 12KB Image download
Fig. 1. 36KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

【 参考文献 】
  • [1]Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: From kitchen to clinic. Mol Nutr Food Res. 2013; 57:1510-28.
  • [2]Prasad S, Aggarwal B. Turmeric, the golden spice: From traditional medicine to modern medicine. Herbal Medicine. 2nd ed. Benzie I, Wachtel-Galor S, editors. FL, USA, CRC Press, Boca Raton; 2011.
  • [3]Lantz RC, Chen GJ, Sarihan M, Solyom AM, Jolad SD, Timmermann BN. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine. 2007; 14:123-8.
  • [4]Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: From bedside to bench and back. Biotech Advances. 2014; 32(6):1053-64.
  • [5]Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012; 26:1719-25.
  • [6]Leach MJ, Kumar S. The clinical effectiveness of ginger (Zingiber officinale) in adults with osteoarthritis. Int J Evid Based Healthc. 2008; 6:311-20.
  • [7]Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. J Affect Disord. 2014; 167:368-75.
  • [8]McDowell K, Clements JN. How can NSAIDs harm cardiovascular and renal function? JAAPA. 2014; 27:12-5.
  • [9]McCarberg B, Gibofsky A. Need to develop new nonsteroidal anti-inflammatory drug formulations. Clin Ther. 2012; 34:1954-63.
  • [10]Tayyem RF, Heath DD, Al-Delaimy WK, Rock CL. Curcumin content of turmeric and curry powders. Nutr Cancer. 2006; 55:126-31.
  • [11]Verghese J, Joy MT. Isolation of the colouring matter from dried turmeric (Curcuma longa L.) with ethyl acetate. Flav Fragr J. 1989; 4:31-2.
  • [12]Asher GN, Spelman K. Clinical utility of curcumin extract. Alt Ther Health Med. 2013; 19:20-2.
  • [13]Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G et al.. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007; 28:1765-73.
  • [14]Samad T, Abdi S. Cyclooxygenase-2 and antagonists in pain management. Curr Op Anaesthesiol. 2001; 14:527-32.
  • [15]Tajik H, Tamaddonfard E, Hamzeh-Gooshchi N. The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats. Pak J Biol Sci. 2008; 11:312-4.
  • [16]De Paz-Campos MA, Chavez-Pina AE, Ortiz MI, Castaneda-Hernandez G. Evidence for the participation of ATP-sensitive potassium channels in the antinociceptive effect of curcumin. Korean J Pain. 2012; 25:221-7.
  • [17]Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Digest Dis Sci. 2005; 50:2191-3.
  • [18]Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors. 2013; 39:2-13.
  • [19]Hsiang CY, Lo HY, Huang HC, Li CC, Wu SL, Ho TY. Ginger extract and zingerone ameliorated trinitrobenzene sulphonic acid-induced colitis in mice via modulation of nuclear factor-κB activity and interleukin-1β signalling pathway. Food Chem. 2013; 136:170-7.
  • [20]Funk JL, Frye JB, Oyarzo JN, Timmermann BN. Comparative effects of two gingerol-containing Zingiber officinale extracts on experimental rheumatoid arthritis. J Nat Prod. 2009; 72:403-7.
  • [21]Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids. 2002; 67:475-8.
  • [22]Terry R, Posadzki P, Watson LK, Ernst E. The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med. 2011; 12:1808-18.
  • [23]Cao R, Fu K, Lv X, Li W, Zhang N. Protective effects of kaempferol on lipopolysaccharide-induced mastitis in mice. Inflammation. 2014; 37(5):1453-8.
  • [24]Shu YS, Tao W, Miao QB, Lu SC, Zhu YB. Galangin dampens mice lipopolysaccharide-induced acute lung injury. Inflammation. 2014; 37(5):1661-8.
  • [25]Narukawa M, Koizumi K, Iwasaki Y, Kubota K, Watanabe T. Galangal pungent component, 1′-acetoxychavicol acetate, activates TRPA1. Biosci Biotech Biochem. 2010; 74:1694-6.
  • [26]Nihayati E, Wardiyati T, Retnowati R, Soemarno S. The curcumin content of temulawak (Curcuma xanthorriza Roxb.) rhizome as affected by N, K, and micronutrients B, Fe, Zn. Agrivita. 2013; 35:218-226.
  • [27]Lee SK, Hong CH, Huh SK, Kim SS, Oh OJ, Min HY et al.. Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells. J Env Pathol Toxicology Oncol. 2002; 21:141-8.
  • [28]Kim MB, Kim C, Song Y, Hwang JK. Antihyperglycemic and anti-inflammatory effects of standardized Curcuma xanthorrhiza Roxb. extract and its active compound xanthorrhizol in high-fat diet-induced obese mice. Evid Based Comp Alt Med. 2014; 205915
  • [29]Devaraj S, Esfahani AS, Ismail S, Ramanathan S, Yam MF. Evaluation of the antinociceptive activity and acute oral toxicity of standardized ethanolic extract of the rhizome of Curcuma xanthorrhiza Roxb. Molecules. 2010; 15:2925-34.
  • [30]Banafshe HR, Hamidi GA, Noureddini M, Mirhashemi SM, Mokhtari R, Shoferpour M. Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. Eur J Pharmacol. 2014; 723:202-6.
  • [31]Zhao X, Xu Y, Zhao Q, Chen CR, Liu AM, Huang ZL. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology. 2012; 62:843-54.
  • [32]Zhu Q, Sun Y, Yun X, Ou Y, Zhang W, Li JX. Antinociceptive effects of curcumin in a rat model of postoperative pain. Sci Rep. 2014; 4:4932.
  • [33]Al-Nahain A, Jahan R, Rahmatullah M. Zingiber officinale: A potential plant against rheumatoid arthritis. Arthritis. 2014; 2014:1-8.
  • [34]Cheppudira B, Fowler M, McGhee L, Greer A, Mares A, Petz L et al.. Curcumin: a novel therapeutic for burn pain and wound healing. Exp Opin Invest Drugs. 2013; 22:1295-303.
  • [35]Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antiox Redox Signal. 2013; 18:1818-92.
  • [36]Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6:e1000100.
  • [37]Black CD, Herring MP, Hurley DJ, O’Connor PJ. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. J Pain. 2010; 11:894-903.
  • [38]Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557-60.
  • [39]Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-34.
  • [40]Becker N, Bondegaard TA, Olsen AK, Sjøgren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 1997; 73:393-400.
  • [41]Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10:287-7.
  • [42]Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt HH et al.. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthr Cartilage. 2000; 8:9-12.
  • [43]Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001; 44:2531-8.
  • [44]Wigler I, Grotto I, Caspi D, Yaron M. The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthr Cartil. 2003; 11:783-9.
  • [45]Drozdov VN, Kim VA, Tkachenko EV, Varvanina GG. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip. J Alt Comp Med. 2012; 18:583-8.
  • [46]Pinsornsak P, Niempoog S. The efficacy of Curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai. 2012; 95:S51-8.
  • [47]Paramdeep G. Efficacy and tolerability of ginger (Zingiber officinale) in patients of osteoarthritis of knee. Indian J Physiol Pharmacol. 2013; 57:177-83.
  • [48]Madhu K, Chanda K, Saji MJ. Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial. Inflammopharmacology. 2013; 21:129-36.
  • [49]Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C et al.. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014; 9:451-8.
  • [50]Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res. 2014; doi:10.1002/ptr.5174
  • [51]Ozgoli G, Goli M, Moattar F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Alt Comp Med. 2009; 15:129-32.
  • [52]Rahnama P, Montazeri A, Huseini HF, Kianbakht S, Naseri M. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. BMC Comp Alt Med. 2012; 12:92. BioMed Central Full Text
  • [53]Drobnic F, Riera J, Appendino G, Togni S, Franceschi F, Valle X et al.. Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial. J Int Soc Sports Nutr. 2014; 11:31. BioMed Central Full Text
  • [54]Agarwal KA, Tripathi CD, Agarwal BB, Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study. Surg Endosc. 2011; 25:3805-10.
  • [55]Bundy R, Walker AF, Middleton RW, Booth J. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Alt Comp Med. 2004; 10:1015-8.
  • [56]Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stutzer H et al.. Herbal medicine with Curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol. 2005; 40:936-43.
  • [57]Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP et al.. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res. 2013; 180:34-43.
  • [58]Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthr Cartil. 2005; 13:769-81.
  • [59]Payne S. Sex, gender, and irritable bowel syndrome: making the connections. Gend Med. 2004; 1:18-28.
  • [60]Novacek G. Gender and gallstone disease. Wien Med Wochenschr. 2006; 156:527-33.
  • [61]DerSimonian R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials. 1986; 7:177-88.
  • [62]Sahebkar A. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin Nutr. 2014; 33:406-14.
  • [63]Lee J, Oh H. Ginger as an antiemetic modality for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis. Oncol Nurs Forum. 2013; 40:163-70.
  • [64]Viljoen E, Visser J, Koen N, Musekiwa A. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014; 13:20. BioMed Central Full Text
  • [65]Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol. 2006; 194:95-9.
  • [66]Kanerva L, Estlander T, Jolanki R. Occupational allergic contact dermatitis from spices. Contact Dermatitis. 1996; 35:157-62.
  • [67]Kandarkar SV, Sawant SS, Ingle AD, Deshpande SS, Maru GB. Subchronic oral hepatotoxicity of turmeric in mice – histopathological and ultrastructural studies. Indian J Exp Biol. 1998; 36:675-9.
  • [68]Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012; 45:221-6.
  • [69]Singh D, Gupta R, Saraf SA. Herbs - are they safe enough? An overview. Crit Rev Food Sci Nutr. 2012; 52:876-98.
  • [70]Spolarich AE, Andrews L. An examination of the bleeding complications associated with herbal supplements, antiplatelet and anticoagulant medications. J Dent Hyg. 2007; 81:67.
  • [71]Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate secretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. 2008; 87:1262-7.
  • [72]Balaji S, Chempakam B. Toxicity prediction of compounds from turmeric (Curcuma longa L.). Chem Toxicol. 2010; 48:2951-9.
  • [73]Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002; 27:391-401.
  • [74]Hodges PJ, Kam PC. The peri-operative implications of herbal medicines. Anaesthesia. 2002; 57:889-99.
  文献评价指标  
  下载次数:0次 浏览次数:14次